PRESS RELEASES
Subscribe to our latest press releases
Jared N. Schwartz, MD, PhD, FCAP, Selected as 2010 Pathologist of the Year by the College of American Pathologists
Aperio Chief Medical Officer Receives Prestigious Award
Jared N.
Schwartz, MD, PhD, FCAP, of Charlotte, N.C., was named the 2010
Pathologist of the Year at a ceremony held on September 26, 2010, in
Chicago at CAP '10 — THE Pathologists' Meeting™.
Dr. Schwartz received the award, the College of American Pathologists'
highest honor, in recognition for his strong leadership of the College
during his term as president from 2007 to 2009, as well as his tireless
contributions to the CAP over the years by serving as a member and chair
of numerous committees and councils, including the International,
Compensation, Finance, Strategic Planning, and National Meeting Planning
Committees and the Council on Scientific Affairs.
"It is always an honor to receive the recognition of one's peers, and I
thank you for this award," said Dr. Schwartz. "I met so many incredible
people that otherwise would never have crossed my path, and I learned
that we all have something to contribute to improve the common good."
Dr. Schwartz has held numerous leadership positions within the College,
having served as CAP president-elect and secretary-treasurer. He also
served as chair of both the Finance Committee and the Ad-Hoc Task Force
on National Preparedness. He has been an active member of numerous other
CAP ad hoc committees, as well. Dr. Schwartz is a longtime member of the
CAP Spokespersons Network, and he currently serves as an alternate
delegate for the World Association of Societies of Pathologists and
Laboratory Medicine (WASPaLM).
Previously, Dr. Schwartz was president of the CAP Foundation Board, as
well as a member of the CAP/JCAHO Lab Committee and the Microbiology
Resource Committee. In addition, Dr. Schwartz served as chair of the
Council on Scientific Affairs, the CAP Web Strategy Task Force, and the
Program and Program Evaluation Committee.
Dr. Schwartz is the chief medical officer for
Aperio Technologies, Inc., and he
currently serves as a consulting professor in the Department of
Pathology at Stanford University in California. Prior to his position
with Aperio, Dr. Schwartz was the director of the Department of
Pathology and Laboratory Medicine at Presbyterian Healthcare in
Charlotte, North Carolina, where he served as a staff pathologist and
chief of the medical staff. At Presbyterian Healthcare, he chaired the
Pathology Peer Review and was a member of the Executive Committee of the
Medical Board, the Cancer Center Strategic Planning Committee, the
Breast Cancer Advisory Committee, and the CEO Physician Leadership
Group. He previously was a medical examiner in Durham County, North
Carolina.
Dr. Schwartz earned his BS in microbiology and his MSc in mycology from
The Ohio State University in Columbus. He received his MD from Duke
University Medical School in Durham, followed by his PhD in pathology
from Duke University Graduate School. Dr. Schwartz completed his
internship, fellowship, and residency at Duke University Medical Center
in the Department of Pathology, where he also served as chief resident
from 1976-1977.
The College of American Pathologists is a medical society serving more
than 17,000 physician members and the laboratory community throughout
the world. It is the world's largest association composed exclusively of
board-certified pathologists and is widely considered the leader in
laboratory quality assurance. The College is an advocate for
high-quality and cost-effective patient care.
SOURCE College of American Pathologists
About Aperio
Aperio is the leading provider of digital pathology solutions in hospitals, reference labs, and biopharma/research institutions across the world. Today, our affordable and complete product portfolio is proven to lower costs, increase efficiencies, and enhance workflow in labs everywhere. Our comprehensive product line features our ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide® slide sharing service for pathology, and image analysis tools and services. Aperio’s products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For clearance updates and more information please visit www.aperio.com.
Contacts:
Jessica Witkowski
Director, Marketing Communications
Aperio
760.539.1162
jessica@aperio.com
Myla Wagner
Myla Wagner Public Relations
925.736.7515
myla@mylawagnerpr.com